Correlation Between Seres Therapeutics and Kineta

Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Kineta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Kineta into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Seres Therapeutics and Kineta Inc, you can compare the effects of market volatilities on Seres Therapeutics and Kineta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Kineta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Kineta.

Diversification Opportunities for Seres Therapeutics and Kineta

0.74

Correlation Coefficient

Seres Therapeutics  Kineta

Poor diversification

The 3 months correlation between Seres and Kineta is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Kineta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kineta Inc and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Kineta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kineta Inc has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Kineta go up and down completely randomly.

Pair Corralation between Seres Therapeutics and Kineta

Given the investment horizon of 90 days Seres Therapeutics is expected to generate 0.41 times more return on investment than Kineta. However, Seres Therapeutics is 2.44 times less risky than Kineta. It trades about -0.09 of its potential returns per unit of risk. Kineta Inc is currently generating about -0.11 per unit of risk. If you would invest  114.00  in Seres Therapeutics on January 28, 2024 and sell it today you would lose (31.00) from holding Seres Therapeutics or give up 27.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	97.73%
Values	Daily Returns

Seres Therapeutics  vs.  Kineta Inc

Seres Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Seres Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Kineta Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kineta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Seres Therapeutics and Kineta

The main advantage of trading using opposite Seres Therapeutics and Kineta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Kineta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kineta will offset losses from the drop in Kineta's long position.

The idea behind Seres Therapeutics and Kineta Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.